JH

Jayantilal Hirji Dama

Active Director Designated Partner DIN 11502039
DIN 11502039 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayantilal Hirji Dama

Data last updated:

Jayantilal Hirji Dama is a Designated Partner at Azira Pharma Llp (since 2026).

DIN 11502039
Primary Designation Designated Partner
First Appointment 23 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Azira Pharma Llp ACU-6497
Designated Partner23 Jan 20262026Active

Board colleagues of Jayantilal Hirji Dama

NameDINCompanyDesignation
Nileshkumar Kanubhai Bhanushali10727199Azira Pharma LlpDesignated Partner
Nitin Shankarlal Bhanushali11502040Azira Pharma LlpDesignated Partner
Rahul Devji Nanda10001682Azira Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Azira Pharma Llp
Premium access

Shareholding and investment profile for Jayantilal Hirji Dama

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayantilal Hirji Dama

Jayantilal Hirji Dama currently holds 1 directorship: Azira Pharma Llp (Designated Partner, since 23 Jan 2026).

Jayantilal Hirji Dama was first appointed on 23 Jan 2026 as Designated Partner at Azira Pharma Llp.

The current boards of Jayantilal Hirji Dama's companies include Nileshkumar Kanubhai Bhanushali (Azira Pharma Llp), Nitin Shankarlal Bhanushali (Azira Pharma Llp), Rahul Devji Nanda (Azira Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available